UK: Hemophiliac wins access to recombinant factor VIII.
On 17 July 2003, the England and Wales High Court granted a hemophiliac leave to appeal a decision to refuse to provide him with recombinant factor VIII, a treatment for hemophilia not derived from human blood. The applicant had been infected with HIV and hepatitis B, C, and G through tainted blood products.
Gold
Jennifer
J
D005169:Factor VIII / Q000627:therapeutic use*; D015658:HIV Infections / Q000150:complications / Q000635:transmission; D006297:Health Services Accessibility; D006467:Hemophilia A / Q000188:drug therapy*; D006509:Hepatitis B / Q000150:complications / Q000635:transmission; D006526:Hepatitis C / Q000150:complications / Q000635:transmission; D006801:Humans; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D006113:United Kingdom
D011994:Recombinant Proteins; D005169:Factor VIII